CN115029815A - Magnetic therapy fiber and preparation method and application thereof - Google Patents
Magnetic therapy fiber and preparation method and application thereof Download PDFInfo
- Publication number
- CN115029815A CN115029815A CN202210801731.0A CN202210801731A CN115029815A CN 115029815 A CN115029815 A CN 115029815A CN 202210801731 A CN202210801731 A CN 202210801731A CN 115029815 A CN115029815 A CN 115029815A
- Authority
- CN
- China
- Prior art keywords
- magnetic therapy
- fiber
- magnetic
- parts
- therapy fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 142
- 238000002653 magnetic therapy Methods 0.000 title claims abstract description 93
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 239000011248 coating agent Substances 0.000 claims abstract description 46
- 229920005989 resin Polymers 0.000 claims abstract description 44
- 239000011347 resin Substances 0.000 claims abstract description 44
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 43
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 26
- 239000010703 silicon Substances 0.000 claims abstract description 26
- 239000004094 surface-active agent Substances 0.000 claims abstract description 26
- 239000004753 textile Substances 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 47
- -1 polyethylene terephthalate Polymers 0.000 claims description 27
- 239000002131 composite material Substances 0.000 claims description 23
- 239000001993 wax Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- 239000004594 Masterbatch (MB) Substances 0.000 claims description 14
- 238000009987 spinning Methods 0.000 claims description 13
- 239000002245 particle Substances 0.000 claims description 11
- 238000002074 melt spinning Methods 0.000 claims description 9
- 239000004743 Polypropylene Substances 0.000 claims description 8
- 229920006242 ethylene acrylic acid copolymer Polymers 0.000 claims description 8
- 229940057995 liquid paraffin Drugs 0.000 claims description 8
- 229920001155 polypropylene Polymers 0.000 claims description 8
- 238000010298 pulverizing process Methods 0.000 claims description 8
- 239000004698 Polyethylene Substances 0.000 claims description 7
- 229920013639 polyalphaolefin Polymers 0.000 claims description 7
- 229920000573 polyethylene Polymers 0.000 claims description 7
- 150000001408 amides Chemical class 0.000 claims description 6
- 238000001125 extrusion Methods 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- 229920001296 polysiloxane Polymers 0.000 claims description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- 229920002292 Nylon 6 Polymers 0.000 claims description 5
- 229920002302 Nylon 6,6 Polymers 0.000 claims description 5
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 5
- 239000004626 polylactic acid Substances 0.000 claims description 5
- 229920002545 silicone oil Polymers 0.000 claims description 5
- 239000004952 Polyamide Substances 0.000 claims description 4
- 229920002647 polyamide Polymers 0.000 claims description 4
- 229920001707 polybutylene terephthalate Polymers 0.000 claims description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 4
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 229920002215 polytrimethylene terephthalate Polymers 0.000 claims description 3
- ZJOLCKGSXLIVAA-UHFFFAOYSA-N ethene;octadecanamide Chemical compound C=C.CCCCCCCCCCCCCCCCCC(N)=O.CCCCCCCCCCCCCCCCCC(N)=O ZJOLCKGSXLIVAA-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000002105 nanoparticle Substances 0.000 claims description 2
- 230000006698 induction Effects 0.000 abstract description 15
- 239000006249 magnetic particle Substances 0.000 abstract description 15
- 230000005389 magnetism Effects 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 11
- 230000036541 health Effects 0.000 abstract description 8
- 230000035790 physiological processes and functions Effects 0.000 abstract description 5
- 230000008092 positive effect Effects 0.000 abstract description 4
- 239000000047 product Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 7
- 238000001000 micrograph Methods 0.000 description 6
- RKISUIUJZGSLEV-UHFFFAOYSA-N n-[2-(octadecanoylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCNC(=O)CCCCCCCCCCCCCCCCC RKISUIUJZGSLEV-UHFFFAOYSA-N 0.000 description 6
- 239000011859 microparticle Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 235000013980 iron oxide Nutrition 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010011878 Deafness Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 231100000895 deafness Toxicity 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000036449 good health Effects 0.000 description 3
- 208000016354 hearing loss disease Diseases 0.000 description 3
- 229910052592 oxide mineral Inorganic materials 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229910052596 spinel Inorganic materials 0.000 description 2
- 239000011029 spinel Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229910052566 spinel group Inorganic materials 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/14—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one polyester as constituent
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/08—Melt spinning methods
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/12—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one polyamide as constituent
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mechanical Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Magnetic Treatment Devices (AREA)
- Artificial Filaments (AREA)
Abstract
The application provides a magnetic therapy fiber and a preparation method and application thereof, relating to the technical field of functional fibers. The magnetic therapy fiber comprises the following raw materials in parts by weight: 30-75 parts of magnet, 40-90 parts of carrier resin, 2-6 parts of silicon surfactant, 1-2 parts of coating agent and 1-2 parts of auxiliary agent. The magnetic therapy fiber is more stable in magnetism, and magnetic particles can be uniformly implanted into the magnetic therapy fiber, so that the magnetic induction intensity of the magnetic therapy fiber is higher, the comfort level of the magnetic therapy fiber is not influenced, the magnetic therapy fiber is blended and then applied to the field of home textiles and clothes, the positive effects of increasing the magnetic field of a human body and improving the physiological function can be achieved, and the magnetic therapy fiber has a better health care effect.
Description
Technical Field
The application relates to the technical field of functional fibers, in particular to a magnetic therapy fiber and a preparation method and application thereof.
Background
The magnetic health-care fibre is characterized by that the permanent-magnet microparticle material is uniformly implanted in the interior of fibre, and organically combined together, and the magnetic fibre is uniformly equipped with microparticle material containing permanent magnet, so that the surface of the fabric has N, S magnetic field, and the magnetic force lines produced by these magnetic microparticles are formed into magnetic circuit from N pole to S pole, and these magnetic force lines are tightly close to the edge of fabric fibre, and several N, S magnetic circuits produced by countless magnetic microparticles and emitted magnetic force lines are interlaced into a layer of three-dimensional magnetic force net, and said net film can be used for making omnibearing three-dimensional stimulation and massage on the skin, so that the skin surface can be in micromotion state, and can activate cell metabolism and promote microcirculation of body, and the magnetic force lines produced by the magnetic microparticles tightly adhered to the skin acupoints can be passed through these acupoints, so that these magnetic force lines can play the same role as Chinese medicine acupuncture and moxibustion, so that it can regulate physiological function of human body, has medical and health care effects.
The existing magnetic fiber products are usually prepared from iron oxides, and are often low in magnetic induction strength or high in magnetic induction strength and low in fiber strength, so that the comfort level is poor, and the health care effect of the magnetic fiber products is poor, so that the use of the magnetic fibers is limited.
Disclosure of Invention
An object of this application is to provide a magnetotherapy fibre, this magnetotherapy fibre magnetic induction is stronger, has better health care effect.
Another object of the present application is to provide a method for preparing a magnetic therapy fiber, which can prepare a magnetic therapy fiber with stable magnetism.
Still another object of the present application is to provide a use of the magnetic therapy fiber.
The technical problem to be solved by the application is solved by adopting the following technical scheme.
On one hand, the embodiment of the application provides a magnetic therapy fiber which comprises the following raw materials in parts by weight: 30-75 parts of magnet, 40-90 parts of carrier resin, 2-6 parts of silicon surfactant, 1-2 parts of coating agent and 1-2 parts of auxiliary agent.
On the other hand, the embodiment of the application provides a preparation method of magnetic therapy fiber, which comprises the following steps:
pulverizing Magnetitum into nanometer powder;
uniformly mixing the nanoscale powder with carrier resin, silicon surfactant, coating agent and auxiliary agent, and extruding and granulating to obtain master batch;
spinning the master batch by a melt spinning method to obtain composite fiber;
magnetizing the composite fiber to obtain the magnetic therapy fiber finished product.
In another aspect, the embodiments of the present application provide an application of the magnetic therapy fiber in home textiles and clothing.
Compared with the prior art, the embodiment of the application has at least the following advantages or beneficial effects:
the magnetic therapy fiber is prepared by selecting the magnet to prepare the magnetic therapy fiber, the magnet is ore with magnetism in the nature, the magnet is oxide mineral spinel magnetite which mainly contains ferroferric oxide, can be used for palpitation and insomnia, light headedness, dim eyesight, tinnitus and deafness and asthma due to deficiency of the kidney, has good health care effect, has fixed magnetism, and can not be demagnetized even after a long time passes, so the magnetic therapy fiber is prepared by mixing the magnet with the carrier resin, the silicon surfactant, the coating agent and the auxiliary agent, the silicon surfactant and the coating agent can ensure that the crushed nano-scale powder is more uniformly dispersed, the nano-scale powder can be rapidly coated, the auxiliary agent can increase the wettability of the coating agent, the coating agent can fully coat the nano-scale powder, and compared with the common iron oxide, the magnetic therapy fiber is more stable in magnetism, and the magnetic particles are uniformly implanted into the magnetic therapy fiber, so that the magnetic induction intensity of the magnetic therapy fiber is higher, the comfort level of the magnetic therapy fiber is not influenced, the magnetic therapy fiber is blended and then applied to the field of home textiles and clothes, the positive effects of increasing the magnetic field of a human body and improving the physiological function can be achieved, and the health care effect is better.
The preparation method is simple and convenient in process, firstly, the magnet substance is crushed into nanoscale powder, the nanoscale powder is conveniently and fully fused with carrier resin during spinning, magnetic particles are favorably and uniformly implanted into the magnetic therapy fibers, the magnetic particles can be ensured to be rapidly and stably magnetized in the subsequent magnetizing step, then, the nanoscale powder is uniformly mixed with the carrier resin, the silicon surfactant, the coating agent and the auxiliary agent, magnetic master batches are prepared after extrusion and granulation, the composite fibers are magnetized, the magnetic induction intensity of the magnetic therapy fibers can be further enhanced, and the magnetic particles can be uniformly distributed in the magnetic fibers.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings that are required to be used in the embodiments will be briefly described below, it should be understood that the following drawings only illustrate some embodiments of the present application and therefore should not be considered as limiting the scope, and for those skilled in the art, other related drawings can be obtained from the drawings without inventive effort.
FIG. 1 is a scanning electron microscope image of a magnetic therapy fiber prepared in example 1 of the present application;
FIG. 2 is a scanning electron microscope image of the magnetic therapy fiber prepared in the embodiment 2 of the present application;
FIG. 3 is a scanning electron microscope image of the magnetotherapeutic fibers prepared in example 3 of the present application;
FIG. 4 is a scanning electron microscope image of the magnetic therapy fiber prepared in the embodiment 4 of the present application;
FIG. 5 is a scanning electron microscope image of the magnetic therapy fiber prepared in the embodiment 5 of the present application;
FIG. 6 is a scanning electron microscope image of the magnetic therapy fiber prepared in the embodiment 6 of the present application.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present application clearer, the technical solutions of the embodiments of the present application will be clearly and completely described below. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
It should be noted that, in the present application, the embodiments and features of the embodiments may be combined with each other without conflict. The present application will be described in detail below with reference to specific examples.
The embodiment of the application provides a magnetic therapy fiber, which comprises the following raw materials in parts by weight: 30-75 parts of magnet, 40-90 parts of carrier resin, 2-6 parts of silicon surfactant, 1-2 parts of coating agent and 1-2 parts of auxiliary agent.
In the embodiment, the magnetic fiber is prepared by the magnet, the carrier resin, the silicon surfactant, the coating agent and the auxiliary agent, the magnet is selected to prepare the magnetic fiber, the magnet is natural ore with magnetism, is oxide mineral spinel magnetite and mainly contains ferroferric oxide, can be used for palpitation and insomnia, dizziness, blurred vision, tinnitus and deafness, deficiency of the kidney and asthma, has good health care effect, has fixed magnetism, and can not be demagnetized even after a long time, so the magnetic fiber is prepared by mixing the magnet with the carrier resin, the silicon surfactant, the coating agent and the auxiliary agent, the silicon surfactant and the coating agent can enable the crushed nano-scale powder to be dispersed more uniformly, the nano-scale powder can be coated rapidly, the auxiliary agent can increase the wettability of the coating agent, the coating agent can fully coat the nano-scale powder, compared with the common iron oxide to prepare the magnetic fiber, the magnetic therapy fiber is more stable in magnetism, and the magnetic particles are uniformly implanted into the magnetic therapy fiber, so that the magnetic induction intensity of the magnetic therapy fiber is higher, the comfort level of the magnetic therapy fiber is not influenced, the magnetic therapy fiber is blended and then applied to the field of home textiles and clothes, the positive effects of increasing the magnetic field of a human body and improving the physiological function can be achieved, and the health care effect is better.
After the magnetic therapy fiber is used, the fabric prepared by blending can promote the metabolism of human cells and activate the cells, thereby accelerating the excretion of intracellular waste and harmful substances and balancing the internal secretion; promoting blood circulation, improving microcirculation, relieving fatigue, and promoting physical recovery; promoting inflammation regression, and eliminating inflammation swelling and pain; regulating blood pressure, and lowering hypertension; improving the oxygen carrying capacity of erythrocytes and reducing the blood viscosity; the free radicals accumulated in the body are eliminated, the resistance is enhanced, and the immunity is improved; also has anti-aging effect, and can clear the free radicals accumulated in the body; improving blood lipid metabolism, and reducing cholesterol; relieving fatigue and promoting physical recovery; tranquilizing the mind, relieving fatigue, and relieving insomnia and mental stress. Therefore, the health-care food has a very good regulating effect on human bodies.
In some embodiments of the present application, the raw materials are, by weight: 55 parts of magnet, 65 parts of carrier resin, 4 parts of silicon surfactant, 1 part of coating agent and 1 part of auxiliary agent.
In some embodiments of the present application, the carrier resin is a fiber-grade resin chip, and the carrier resin is one or more of polyethylene terephthalate, polypropylene terephthalate, polybutylene terephthalate, polylactic acid, polyamide 6, polyamide 56, and polyamide 66. The carrier resin can be used as a carrier of master batches, so that the magnetic particles are uniformly distributed on the carrier resin.
In some embodiments of the present application, the coating agent is one or more of polyalphaolefin, silicone oil, vegetable oil, and liquid paraffin. The coating agent is used for coating the magnet powder, so that the dispersion of the magnet powder is more uniform, and the nanoscale powder is quickly coated.
In some embodiments of the present application, the auxiliary agent is one or more of silicone auxiliary agent, ethylene bis-stearic acid amide, ethylene acrylic acid copolymer, amide wax, polyethylene wax, and polypropylene wax. The auxiliary agent can increase the wettability of the coating agent, so that the coating agent is dispersed in the auxiliary agent, and the coating agent uniformly coats the magnet powder in the auxiliary agent.
The embodiment of the application also provides a preparation method of the magnetic therapy fiber, which comprises the following steps:
pulverizing Magnetitum into nanometer powder;
mixing the nanoscale powder with carrier resin, silicon surfactant, coating agent and auxiliary agent, extruding, and granulating to obtain master batch;
spinning the master batch by a melt spinning method to obtain composite fiber;
magnetizing the composite fiber to obtain the magnetic therapy fiber finished product.
In the embodiment, the preparation method is simple and convenient in process, firstly, the magnet substance is crushed into nanoscale powder, the nanoscale powder is conveniently and fully fused with carrier resin during spinning, magnetic particles are favorably and uniformly implanted into the magnetic therapy fibers, the magnetic particles can be quickly and stably magnetized in the subsequent magnetizing step, then, the nanoscale powder is uniformly mixed with the carrier resin, the silicon surfactant, the coating agent and the auxiliary agent, magnetic master batches are prepared after extrusion and granulation, the composite fibers are magnetized, the magnetic induction intensity of the magnetic therapy fibers can be further enhanced, and the magnetic particles can be uniformly distributed in the magnetic fibers.
In some examples of the present application, the magnetite is pulverized to a nano-sized powder having an average particle size of 30nm to 200nm using a jet mill. The magnetite substance is crushed into nanoscale powder, so that the nanoscale powder can be fully fused with carrier resin in the subsequent spinning step, the spinneret orifices can be easily blocked due to too large particle size of the powder, and the dispersion effect can be influenced due to too small particle size of the powder, so that the particle size of the powder needs to be controlled within a proper range.
In some embodiments of the present application, in the step of preparing the master batch, the extrusion and granulation are performed by using a twin-screw extruder at 180-280 ℃.
In some embodiments of the present application, the composite fiber is magnetized under 12000-20000 gauss for 1-3 min. Through quick magnetization, can make the magnetic particle distribution in the magnetotherapy fibre more even, magnetism is more stable, can also strengthen the magnetic strength of magnetotherapy fibre.
The embodiment of the application also provides application of the magnetic therapy fiber in home textiles and clothing. The magnetic therapy fiber can be used for manufacturing bedding, waistlines, neck protectors, underwear, socks, insoles and the like, and further can carry out omnibearing three-dimensional stimulation and massage on the close skin, promote the local blood circulation of a human body and achieve the aims of ventilation and detention.
The features and properties of the present application are described in further detail below with reference to examples.
Example 1
A magnetic therapy fiber is prepared by the following steps:
pulverizing 55g of magnet into nanoscale powder with average particle size of 100nm by jet mill;
uniformly mixing the nanoscale powder with 65g of carrier resin, 4g of silicon surfactant, 1g of coating agent and 1g of auxiliary agent, and extruding and granulating by using a double-screw extruder at 230 ℃ to obtain master batches;
the carrier resin is a fiber-grade resin slice, the carrier resin is a mixture of polyethylene terephthalate, polytrimethylene terephthalate, polybutylene terephthalate, polylactic acid, polyamide 6, polyamide 56 and polyamide 66, the coating agent is a mixture of poly-alpha-olefin, silicone oil, vegetable oil and liquid paraffin, and the auxiliary agent is a mixture of silicone auxiliary agent, ethylene bis-stearamide, ethylene acrylic acid copolymer, amide wax, polyethylene wax and polypropylene wax;
spinning the master batch by a melt spinning method to obtain composite fiber;
magnetizing the composite fiber under the magnetic field intensity of 14000 gauss for 2min to obtain the finished product of the magnetic therapy fiber, wherein figure 1 shows the scanning image of the magnetic therapy fiber under the 20 mu m electron microscope.
The finished product of the magnetic therapy fiber is applied to body shaping clothes.
Example 2
A magnetic therapy fiber is prepared by the following steps:
pulverizing 30g of Magnetitum into nanoscale powder with average particle diameter of 30nm by jet mill;
uniformly mixing the nanoscale powder with 40g of carrier resin, 2g of silicon surfactant, 1g of coating agent and 1g of auxiliary agent, and extruding and granulating by using a double-screw extruder at 180 ℃ to obtain master batches;
the carrier resin is a fiber-grade resin slice, the carrier resin is a mixture of polyethylene glycol terephthalate, polylactic acid, polyamide 6, polyamide 56 and polyamide 66, the coating agent is a mixture of poly-alpha-olefin and liquid paraffin, and the auxiliary agent is a mixture of ethylene bisstearamide, an ethylene acrylic acid copolymer, amide wax, polyethylene wax and polypropylene wax;
spinning the master batch by a melt spinning method to obtain composite fiber;
magnetizing the composite fiber under the magnetic field intensity of 12000 gauss for 1min to obtain the finished product of the magnetic therapy fiber, and showing an electron microscope scanning image of the magnetic therapy fiber under 20 mu m in figure 2.
The finished product of the magnetic therapy fiber is applied to bedding.
Example 3
A magnetic therapy fiber is prepared by the following steps:
pulverizing 75g of magnet into nanoscale powder with average particle size of 200nm by jet mill;
uniformly mixing the nanoscale powder with 90g of carrier resin, 6g of silicon surfactant, 2g of coating agent and 2g of auxiliary agent, and extruding and granulating by using a double-screw extruder at 280 ℃ to obtain master batches;
the coating agent is a mixture of poly-alpha-olefin, vegetable oil and liquid paraffin, and the auxiliary agent is a mixture of silicone auxiliary agent, ethylene bis-stearamide, ethylene acrylic acid copolymer and polypropylene wax;
spinning the master batch by a melt spinning method to obtain composite fiber;
magnetizing the composite fiber under the magnetic field intensity of 20000 gauss for 3min to obtain the final product of the magnetic therapy fiber, and FIG. 3 is an electron microscope scanning image of the magnetic therapy fiber under 40 μm.
The finished product of the magnetic therapy fiber is applied to socks.
Example 4
A magnetic therapy fiber is prepared by the following steps:
pulverizing 60g of magnet into nanoscale powder with average particle size of 150nm by jet mill;
uniformly mixing the nanoscale powder with 70g of carrier resin, 3g of silicon surfactant, 1.3g of coating agent and 1.6g of auxiliary agent, and extruding and granulating by using a double-screw extruder at 220 ℃ to obtain master batches;
the coating agent is a mixture of poly-alpha-olefin, silicone oil and liquid paraffin, and the auxiliary agent is a mixture of silicone auxiliary agent, ethylene bis stearamide, ethylene acrylic acid copolymer, amide wax, polyethylene wax and polypropylene wax;
spinning the master batch by a melt spinning method to obtain composite fiber;
magnetizing the composite fiber under the magnetic field intensity of 18000 gauss for 2.5min to obtain the finished product of the magnetic therapy fiber, and showing an electron microscope scanning image of the magnetic therapy fiber under the condition of 10 mu m in figure 4.
The finished product of the magnetic therapy fiber is applied to neck protection.
Example 5
A magnetic therapy fiber is prepared by the following steps:
crushing 45g of magnets into nano-scale powder with the average particle size of 90nm by adopting an airflow mill;
uniformly mixing the nanoscale powder with 66g of carrier resin, 5g of silicon surfactant, 1.7g of coating agent and 1.4g of auxiliary agent, and extruding and granulating by using a double-screw extruder at 220 ℃ to obtain master batches;
the carrier resin is a fiber-grade resin slice, the carrier resin is a mixture of polyethylene terephthalate, polytrimethylene terephthalate, polybutylene terephthalate, polylactic acid, polyamide 6 and polyamide 66, the coating agent is a mixture of silicone oil, vegetable oil and liquid paraffin, and the auxiliary agent is a mixture of a silicone auxiliary agent, ethylene bis stearamide, an ethylene acrylic acid copolymer, polyethylene wax and polypropylene wax;
spinning the master batch by a melt spinning method to obtain composite fiber;
magnetizing the composite fiber under the magnetic field intensity of 19000 gauss for 2.6min to obtain the finished product of the magnetic therapy fiber, wherein figure 5 shows the scanning image of the magnetic therapy fiber under the condition of 10 mu m.
The finished product of the magnetic therapy fiber is applied to insoles.
Example 6
A magnetic therapy fiber is prepared by the following steps:
pulverizing 55g of magnet into nanoscale powder with average particle size of 80nm by jet mill;
uniformly mixing the nanoscale powder with 70g of carrier resin, 3g of silicon surfactant, 1.3g of coating agent and 1.8g of auxiliary agent, and extruding and granulating by using a double-screw extruder at 190 ℃ to obtain master batches;
the coating agent is a mixture of poly-alpha-olefin, vegetable oil and liquid paraffin, and the auxiliary agent is a mixture of ethylene bis stearamide, ethylene acrylic acid copolymer, amide wax, polyethylene wax and polypropylene wax;
spinning the master batch by a melt spinning method to obtain composite fiber;
magnetizing the composite fiber under the magnetic field intensity of 13000 gauss for 1.5min to obtain the finished product of the magnetic therapy fiber, wherein figure 6 shows the scanning image of the magnetic therapy fiber under the electron microscope of 10 mu m.
The finished product of the magnetic therapy fiber is applied to caps.
Examples of the experiments
Magnetic properties of the textile prepared by blending the magnetic therapy fibers finally when master batches with different proportions are added in example 1 are evaluated according to a magnetic field intensity measurement method in appendix C of CAS115-2005 health care functional textile.
The magnetic properties of the magnetic textile were evaluated in the following manner:
when the magnetic induction intensity is more than or equal to 0.02mT and less than 0.10mT, the textile has magnetism;
when the magnetic induction intensity is more than or equal to 0.10mT, the textile has stronger magnetism.
The test results are shown in table 1 below.
TABLE 1
As can be seen from Table 1, the addition ratio of the master batches is increased, the iron content of the magnetic therapy fiber is correspondingly increased, and the magnetic induction intensity of the textile is further enhanced, and even under the condition that the addition ratio of the master batches is smaller or the blending ratio of the magnetic therapy fiber is lower, the magnetic induction intensity of the textile obtained by final blending is still between 0.02mT and 0.1mT, which indicates that the textile has magnetism, so that the magnetic induction intensity of the magnetic therapy fiber prepared by the embodiment of the application is higher.
In summary, the embodiment of the present application provides a magnetic therapy fiber, which is prepared from a magnet, a carrier resin, a silicon surfactant, a coating agent and an auxiliary agent, wherein the magnet is selected to prepare the magnetic therapy fiber, the magnet is an ore with magnetism in the nature, and is an oxide mineral, namely, spinel group magnetite, which mainly contains ferroferric oxide, can be used for palpitation and insomnia, dizziness, blurred vision, tinnitus and deafness, and asthma, and has good health care effects, the magnetism of the magnet is fixed, and the magnet cannot be demagnetized even after a long time, so the magnet is mixed with the carrier resin, the silicon surfactant, the coating agent and the auxiliary agent to prepare the magnetic therapy fiber, the silicon surfactant and the coating agent can enable the crushed nanoscale powder to be dispersed more uniformly, thereby realizing the rapid coating of the nanoscale powder, and the auxiliary agent can increase the wettability of the coating agent, so that the coating agent can fully coat the nanoscale powder, compared with the common iron oxide, the magnetic therapy fiber is more stable in magnetism, and magnetic particles are uniformly implanted into the magnetic therapy fiber, so that the magnetic induction intensity of the magnetic therapy fiber is higher, the comfort level of the magnetic therapy fiber is not influenced, the magnetic therapy fiber is blended and then applied to the field of home textiles and clothes, the positive effects of increasing the magnetic field of a human body and improving the physiological function can be achieved, and the magnetic therapy fiber has a better health care effect.
The embodiment of the application also provides a preparation method of the magnetic therapy fiber, the preparation method is simple and convenient in process, firstly, magnet substances are crushed into nanoscale powder, the nanoscale powder is conveniently and fully fused with carrier resin during spinning, magnetic particles are favorably and uniformly implanted into the magnetic therapy fiber, the magnetic particles can be ensured to be quickly and stably magnetized in the subsequent magnetizing step, then, the nanoscale powder is uniformly mixed with the carrier resin, silicon surface active agent, coating agent and auxiliary agent, magnetic master batches are prepared after extrusion and granulation, the composite fiber is magnetized, the magnetic induction intensity of the magnetic therapy fiber can be further enhanced, and the magnetic particles can be uniformly distributed in the magnetic fiber.
The embodiments described above are some, but not all embodiments of the present application. The detailed description of the embodiments of the present application is not intended to limit the scope of the claimed application, but is merely representative of selected embodiments of the application. All other embodiments obtained by a person of ordinary skill in the art based on the embodiments in the present application without making any creative effort belong to the protection scope of the present application.
Claims (10)
1. The magnetic therapy fiber is characterized by comprising the following raw materials in parts by weight: 30-75 parts of magnet, 40-90 parts of carrier resin, 2-6 parts of silicon surfactant, 1-2 parts of coating agent and 1-2 parts of auxiliary agent.
2. The magnetic therapy fiber according to claim 1, characterized in that the raw materials are respectively, by weight: 55 parts of magnet, 65 parts of carrier resin, 4 parts of silicon surfactant, 1 part of coating agent and 1 part of auxiliary agent.
3. The magnetic therapy fiber according to claim 1, wherein the carrier resin is fiber-grade resin slice, and the carrier resin is one or more of polyethylene terephthalate, polytrimethylene terephthalate, polybutylene terephthalate, polylactic acid, polyamide 6, polyamide 56 and polyamide 66.
4. The magnetic therapy fiber according to claim 1, wherein the coating agent is one or more of poly-alpha-olefin, silicone oil, vegetable oil and liquid paraffin.
5. The magnetic therapy fiber according to claim 1, wherein the auxiliary agent is one or more of silicone auxiliary agent, ethylene bis-stearic acid amide, ethylene acrylic acid copolymer, amide wax, polyethylene wax and polypropylene wax.
6. A process for preparing a magnetotherapeutic fiber according to any one of claims 1 to 5, comprising the steps of:
pulverizing Magnetitum into nanometer powder;
uniformly mixing the nanoscale powder with carrier resin, silicon surfactant, coating agent and auxiliary agent, and performing extrusion granulation to obtain master batch;
spinning the master batch by a melt spinning method to obtain composite fiber;
and magnetizing the composite fiber to obtain the finished product of the magnetic therapy fiber.
7. The process for producing a magnetotherapeutic fiber according to claim 6, wherein the magnet is pulverized by an air jet mill into a nano-sized powder having an average particle diameter of 30nm to 200 nm.
8. The method for preparing magnetotherapeutic fiber according to claim 6, wherein in the step of preparing the master batch, extrusion granulation is performed at 180-280 ℃ using a twin-screw extruder.
9. The method for preparing magnetic therapy fiber according to claim 6, wherein the composite fiber is magnetized under 12000-20000 gausses of magnetic field strength for 1-3 min.
10. Use of a magnetotherapeutic fibre as claimed in any one of claims 1 to 5 in the field of home textiles and clothing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210801731.0A CN115029815A (en) | 2022-07-08 | 2022-07-08 | Magnetic therapy fiber and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210801731.0A CN115029815A (en) | 2022-07-08 | 2022-07-08 | Magnetic therapy fiber and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115029815A true CN115029815A (en) | 2022-09-09 |
Family
ID=83128156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210801731.0A Pending CN115029815A (en) | 2022-07-08 | 2022-07-08 | Magnetic therapy fiber and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115029815A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101168865A (en) * | 2007-11-28 | 2008-04-30 | 盛虹集团有限公司 | Magnetic terylene fibre and producing method thereof |
| CN102330176A (en) * | 2011-05-25 | 2012-01-25 | 高莉萍 | Production method for magnetic terylene fiber |
| CN104746169A (en) * | 2013-12-31 | 2015-07-01 | 上海水星家用纺织品股份有限公司 | Preparation technology of coconut charcoal loaded magnet functional fibers and application thereof |
| CN108251915A (en) * | 2018-01-30 | 2018-07-06 | 舟山欣欣化纤有限公司 | Long-acting strong magnetic fiber long filament of rare earth permanent-magnetic material and preparation method thereof |
| CN108301065A (en) * | 2018-01-30 | 2018-07-20 | 舟山欣欣化纤有限公司 | The long-acting strong magnetic staple fiber and its small lot preparation method of rare earth permanent-magnetic material |
| CN108360078A (en) * | 2018-01-30 | 2018-08-03 | 苏州宝力塑胶材料有限公司 | Strong magnetic fiber magnetic master batch and preparation method thereof |
| CN108360084A (en) * | 2018-01-30 | 2018-08-03 | 苏州宝力塑胶材料有限公司 | Long-acting strong magnetic fiber long filament of rare earth permanent-magnetic material and preparation method thereof |
-
2022
- 2022-07-08 CN CN202210801731.0A patent/CN115029815A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101168865A (en) * | 2007-11-28 | 2008-04-30 | 盛虹集团有限公司 | Magnetic terylene fibre and producing method thereof |
| CN102330176A (en) * | 2011-05-25 | 2012-01-25 | 高莉萍 | Production method for magnetic terylene fiber |
| CN104746169A (en) * | 2013-12-31 | 2015-07-01 | 上海水星家用纺织品股份有限公司 | Preparation technology of coconut charcoal loaded magnet functional fibers and application thereof |
| CN108251915A (en) * | 2018-01-30 | 2018-07-06 | 舟山欣欣化纤有限公司 | Long-acting strong magnetic fiber long filament of rare earth permanent-magnetic material and preparation method thereof |
| CN108301065A (en) * | 2018-01-30 | 2018-07-20 | 舟山欣欣化纤有限公司 | The long-acting strong magnetic staple fiber and its small lot preparation method of rare earth permanent-magnetic material |
| CN108360078A (en) * | 2018-01-30 | 2018-08-03 | 苏州宝力塑胶材料有限公司 | Strong magnetic fiber magnetic master batch and preparation method thereof |
| CN108360084A (en) * | 2018-01-30 | 2018-08-03 | 苏州宝力塑胶材料有限公司 | Long-acting strong magnetic fiber long filament of rare earth permanent-magnetic material and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109355729B (en) | Manufacturing method of Taiji stone and polyester fiber composite material | |
| CN101117747B (en) | Multifunctional composite fiber fabric and manufacturing method therefor | |
| CN105624833B (en) | The preparation method of magnetic alginate fibre | |
| CN101058901B (en) | Nano pearl polypropylene superfine Denier fibre and preparation method thereof | |
| KR20160027318A (en) | Cosmetic Sheets and Method for Manufacturing the Same | |
| CN101314873A (en) | Preparation of polypropylene nano-magnetic fibre | |
| CN102011205A (en) | Germanium viscose fiber and preparation method thereof | |
| CN1293278A (en) | Health-care far infrared and negative oxygen ion fabric and its preparing process | |
| CN105648575A (en) | Copper-modified fibers and blended fabric produced by same | |
| CN105709674A (en) | Temperature-controllable health-care microcapsule and preparation method thereof | |
| CN104060342A (en) | Fabric with mosquito repelling function and manufacturing method thereof | |
| CN115029815A (en) | Magnetic therapy fiber and preparation method and application thereof | |
| CN113774521A (en) | Sea-island type nano composite fiber and preparation method thereof | |
| CN107142541A (en) | A kind of superfine notoginseng powder cellulose fibre, its preparation method and its application | |
| KR101879119B1 (en) | Functional cosmetic fiber and preparation method thereof | |
| CN1318665C (en) | Tourmaline magnetic fibre and manufacturing method thereof | |
| TWM328457U (en) | Fiber products having multi-function thermal diffusive and cooling performances | |
| CN108342786A (en) | A kind of acrylic fiber and preparation method thereof with magnetite health-care physiotherapeutic function | |
| CN1294208A (en) | Synthetic negative-ion far infrared fibre and its preparing process | |
| US20180028712A1 (en) | Skin-regenerating material comprising synergistic combination of metal oxides | |
| WO2001025514A1 (en) | Fibre and fabrics with magnetic material | |
| CN105926081A (en) | New metal-modified fiber material and preparation method thereof | |
| CN105951198A (en) | Method for preparing polyester fiber containing waste hair activated carbon | |
| CN205874848U (en) | Silk non -weaving cloth | |
| CN108360084A (en) | Long-acting strong magnetic fiber long filament of rare earth permanent-magnetic material and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220909 |